GAMMA Investing LLC grew its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS – Free Report) by 26.4% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,673 shares of the company’s stock after purchasing an additional 349 shares during the period. GAMMA Investing LLC’s holdings in Addus HomeCare were worth $193,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Addus HomeCare in the first quarter valued at approximately $41,000. Caitong International Asset Management Co. Ltd raised its position in Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company’s stock valued at $124,000 after buying an additional 987 shares during the last quarter. Bailard Inc. bought a new position in Addus HomeCare during the 1st quarter valued at $208,000. Heritage Family Offices LLP boosted its holdings in Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company’s stock worth $239,000 after acquiring an additional 143 shares during the last quarter. Finally, Private Advisor Group LLC boosted its holdings in Addus HomeCare by 52.4% during the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company’s stock worth $252,000 after acquiring an additional 875 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
Several analysts have recently commented on ADUS shares. Royal Bank Of Canada increased their target price on shares of Addus HomeCare from $133.00 to $134.00 and gave the company an “outperform” rating in a report on Friday, August 22nd. Wall Street Zen upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Sunday, June 29th. JMP Securities restated a “market outperform” rating and issued a $150.00 target price on shares of Addus HomeCare in a research note on Wednesday, July 16th. Stephens reaffirmed an “overweight” rating and issued a $140.00 target price on shares of Addus HomeCare in a report on Wednesday, September 3rd. Finally, Barclays lifted their price target on Addus HomeCare from $83.00 to $109.00 and gave the stock an “underweight” rating in a report on Tuesday, August 19th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $138.89.
Insiders Place Their Bets
In related news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the sale, the chief executive officer directly owned 166,461 shares in the company, valued at approximately $19,134,691.95. This represents a 13.06% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Brian Poff sold 7,739 shares of Addus HomeCare stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $116.82, for a total transaction of $904,069.98. Following the completion of the transaction, the executive vice president owned 56,980 shares of the company’s stock, valued at $6,656,403.60. This represents a 11.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 34,310 shares of company stock worth $3,958,375 over the last quarter. 4.50% of the stock is currently owned by company insiders.
Addus HomeCare Stock Performance
NASDAQ:ADUS opened at $117.34 on Monday. The company has a market capitalization of $2.16 billion, a P/E ratio of 25.90, a P/E/G ratio of 1.79 and a beta of 0.85. The business has a fifty day simple moving average of $112.37 and a two-hundred day simple moving average of $108.54. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.74 and a quick ratio of 1.74. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $136.72.
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm had revenue of $349.44 million for the quarter, compared to analysts’ expectations of $345.71 million. During the same quarter in the prior year, the firm earned $1.35 EPS. The business’s revenue for the quarter was up 21.8% compared to the same quarter last year. On average, analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Further Reading
- Five stocks we like better than Addus HomeCare
- What does consumer price index measure?
- SoundHound Breaks Critical Resistance: How High Can It Get Now?
- How to Effectively Use the MarketBeat Ratings Screener
- Klarna IPO: BNPL Stock or Something Bigger?
- P/E Ratio Calculation: How to Assess Stocks
- Why Teradyne Is a Core Play in the AI Hardware Boom
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.